Could childhood trauma fuel skin inflammation?
NCT ID NCT05507125
First seen Aug 07, 2026 ยท Last updated Aug 07, 2026
Summary
This study investigates how inflammatory genes are regulated in people with hidradenitis suppurativa (HS), a chronic skin condition causing painful lumps. Researchers will compare inflammatory markers in HS patients versus healthy controls. An optional sub-study explores whether childhood trauma influences HS development. The goal is to better understand the disease mechanisms, which could inform future treatments.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- What this could lead to
- If successful, this research could uncover new targets for treating hidradenitis suppurativa and highlight the role of early-life stress in inflammatory skin disease.
- What could go wrong
- This is an observational study, so it won't directly test a treatment. The findings may not lead to new therapies, and the link between childhood trauma and HS is still uncertain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIDRADENITIS SUPPURATIVA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Whitaker Clinic
RECRUITINGBirmingham, Alabama, 35294, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Head-to-Head: which pill tames hidradenitis suppurativa best?
- Skin disease evolution under the microscope: a 17-Year look at what drives severity
- Could early treatment tame a painful skin condition?
- New pill shows promise for controlling painful skin condition in long-term trial
- New shot could ease painful skin condition
- New pill for painful skin disease enters first human tests